Supernus (SUPN) Gross Margin (2013 - 2026)
Supernus Pharmaceuticals (SUPN) reported Gross Margin of 88.09% for Q3 2026, down 2.04 percentage points from 90.13% a year earlier but up 3.46 percentage points from the prior quarter.
Powered by 
Analysis
Supernus (SUPN) Gross Margin (2013 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Supernus Pharmaceuticals' Gross Margin came in at 87.92%, down 0.69 percentage points year-over-year; for FY2025, it came in at 89.63%, up 1.40 percentage points from FY2024.
- Gross Margin has a five-year change of -0.29 percentage points (FY2020 to FY2025).
- By year, Gross Margin came in at 88.23% in FY2024 (+2.02 pp), 86.21% in FY2023 (-0.72 pp), 86.93% in FY2022 (-0.13 pp) and 87.05% in FY2021 (-2.87 pp).
- Five-year quarterly Gross Margin spans a low of 84.44% in Q2 2023 and a high of 90.13% in Q3 2025.
- Year over year, Gross Margin gained in four of the last seven quarters, with an average year-over-year change of -0.68 percentage points.
- The high point for year-over-year Gross Margin in five years was Q2 2022 (a gain of 5.68 percentage points); the low point was Q2 2026 (a drop of 5.20 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 75.71% |
| 10 | Supernus | 1.62 Bn | 196.50 Mn | 199.75 Mn | 88.09% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 88.09% |
| Jun 30, 2026 | 84.63% |
| Dec 31, 2025 | 89.13% |
| Sep 30, 2025 | 90.13% |
| Jun 30, 2025 | 89.83% |
| Mar 31, 2025 | 89.48% |
| Dec 31, 2024 | 85.01% |
| Sep 30, 2024 | 89.99% |
| Jun 30, 2024 | 89.36% |
| Mar 31, 2024 | 88.65% |
| Dec 31, 2023 | 88.06% |
| Sep 30, 2023 | 87.26% |
| Jun 30, 2023 | 84.44% |
| Mar 31, 2023 | 84.74% |
| Dec 31, 2022 | 86.28% |
| Sep 30, 2022 | 85.41% |
| Jun 30, 2022 | 87.97% |
| Mar 31, 2022 | 88.24% |
| Dec 31, 2021 | 89.32% |
| Sep 30, 2021 | 87.82% |
API Access
Supernus Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();